Association between patient reported quality of life (QOL) and survival: Analysis of E3805 chemohormonal androgen ablation randomized trial in prostate cancer

A. K. Morgans, Y. H. Chen, D. Jerrard, M. A. Carducci, R. Dipaola, L. Wagner, D. Cella, C. Sweeney

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)viii291
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
StatePublished - Oct 1 2018

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this